Hims’ Super Bowl ad has drawn criticism from lawmakers — and now Novo Nordisknews2025-02-10T17:43:24+00:00February 10th, 2025|Endpoints News|
Digital health dealmaking is heating upnews2025-02-06T17:07:01+00:00February 6th, 2025|Endpoints News|
Personify Health shares 2024 revenue, profitabilitynews2025-02-06T14:00:58+00:00February 6th, 2025|Endpoints News|
Teladoc to buy Catapult Health for $65Mnews2025-02-05T22:05:07+00:00February 5th, 2025|Endpoints News|
Novo Nordisk is feeling the competition from compounded GLP-1s, exec saysnews2025-02-05T19:33:53+00:00February 5th, 2025|Endpoints News|
How opioid addiction treatment startup Bicycle Health reached a profitnews2025-02-04T14:47:38+00:00February 4th, 2025|Endpoints News|
Noom cuts coaches, staff as fewer sign upnews2025-02-03T19:16:57+00:00February 3rd, 2025|Endpoints News|
Hims is making its Super Bowl debut with an ad that goes straight for pharmanews2025-01-30T16:40:22+00:00January 30th, 2025|Endpoints News|
How Define Ventures thinks health tech startups will exit in 2025news2025-01-30T14:03:54+00:00January 30th, 2025|Endpoints News|
23andMe weighs a sale as cash dwindlesnews2025-01-29T16:06:56+00:00January 29th, 2025|Endpoints News|
